Omeros reported $0 in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.44M 0.44M
Adma Biologics ADMA:US $ 29.1M 2.72M
Aerie Pharmaceuticals AERI:US $ 29.84M 84.83M
Alnylam Pharmaceuticals ALNY:US $ 213.26M 45.28M
Biomarin Pharmaceutical BMRN:US $ 519.36M 69.55M
Cytokinetics CYTK:US $ 1.15M 54.45M
Dynavax Technologies DVAX:US $ 113.99M 81.08M
Gilead Sciences GILD:US $ 6590M 654M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Insmed INSM:US $ 53.11M 3.02M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Knight Therapeutics Inc GUD:CN C$ 63.81M 5.53M
Macrogenics MGNX:US $ 11.1M 3.05M
Mirati Therapeutics MRTX:US $ 0.71M 0.41M
Pacira Pharmaceuticals PCRX:US $ 157.99M 1.2M
Pfizer PFE:US $ 25661M 2026M
Sangamo Biosciences SGMO:US $ 28.23M 0.24M
Sarepta Therapeutics SRPT:US $ 210.83M 9.37M
United Therapeutics UTHR:US $ 461.9M 46.7M
Vertex Pharmaceuticals VRTX:US $ 2097.5M 24.94M
Xoma XOMA:US $ 3.11M 32.84M